Clinical Trials · NCT04034524
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 20,000
- Start date
- May 2019
- Locations
- 1 site, United States
- Primary endpoint
- Time until first composite CV event (myocardial infarction, stroke)